Article Text

Download PDFPDF
Local Control After Tailored Surgical Treatment of Early Cervical Cancer
  1. David Cibula, MD, PhD*,
  2. Ivana Pinkavova, MD*,
  3. Ladislav Dusek, MD, PhD,
  4. Jiri Slama, MD, PhD*,
  5. Michael Zikan, MD, PhD*,
  6. Daniela Fischerova, MD, PhD*,
  7. Pavel Freitag, MD, PhD* and
  8. Pavel Dundr, MD, PhD
  1. * Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University, Prague;
  2. Institute of Biostatistics and Analyses, Masaryk University, Brno; and
  3. Department of Pathology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
  1. Address correspondence and reprint requests to David Cibula, MD, PhD, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Apolinarska 18, Prague 2, Czech Republic. E-mail: david.cibula{at}iol.cz.

Abstract

Background: It was the aim of our study to analyze oncological outcome and prognostic parameters in patients with early stages cervical cancer after tailored and well-standardized surgical treatment with an adequate follow-up.

Methods: Oncological outcome and prognostic parameters were evaluated in a group of 192 patients with cervical cancer stages IA2 to 2B who had undergone radical hysterectomy (n = 171), radical parametrectomy (n = 12), or radical trachelectomy (n = 9). Procedures were classified as type B (n = 72), type C1 nerve sparing (n = 103), or type C2 (n = 17).

Results: Event-free and overall 5-year survivals probabilities reached 92.7% (confidence interval, 89.5%-95.9 %) and 94.1% (confidence interval, 90.9%-97.3 %). There was only 1 isolated pelvic recurrence found of the total of 10 recurrences. Adjuvant radiotherapy was given to only 22% of patients. The most significant independent prognostic parameters in stage IB tumors were lymph node status, histological type, and tumor volume, whereas in stage II, the parameters included histological type and tumor volume, the latter being inversely related to the prognosis.

Conclusions: We have shown an excellent prognosis, especially local control, after tailored surgical treatment of stages IA2 to IIB of cervical cancer, with low prevalence of adjuvant treatment. Different prognostic parameters were observed for stages IB1/IB2 and IIA/B.

  • Cervical cancer
  • Surgical treatment
  • Radical hysterectomy
  • Local control
  • Survival

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.